Danaher Corp. acquires Nobel Biocare

September 15, 2014

In a major development in the world of dental implants. Danaher Corporation has entered into a definitive transaction agreement to acquire Nobel Biocare Holding AG, a world leader in implant dentistry.

In a major development in the world of dental implants. Danaher Corporation has entered into a definitive transaction agreement to acquire Nobel Biocare Holding AG, a world leader in implant dentistry.

According to a press release, Nobel Biocare will be a cornerstone of Danaher’s dental platform. With the addition of Nobel Biocare, Danaher will be one of the strongest consumable and equipment player in the dental industry, with sales approaching $3 billion. Dental implants is a $3.5 billion market with attractive long term growth drivers, including an aging population, growing income in high growth markets and low penetration rates of dental implants in most geographies today. Nobel Biocare will operate as a stand-alone company within Danaher's dental platform, maintaining its own brand and identity. Implant Direct will remain as a stand-alone joint venture with no change in its go to market strategy.

Related: Henk van Duijnhoven discusses the recent changes in Danaher's brand strategy

"We will continue to invest in a wide range of dental technologies and innovations to better serve our customers. Bringing Nobel Biocare's deep expertise in implant dentistry, digital prosthetics and software solutions together with our extensive knowledge in 3D imaging, intraoral scanning and digital restorative solutions will further enable us to optimize and integrate workflows. This will lead to better clinical outcomes, shorter treatment times and fewer office visits to the benefit of patients and dental practitioners," said Henk van Duijnhoven, Senior Vice President of Danaher's dental platform. "This combination will further support our business strategy and position our dental business for future growth."

Read all about Nobel Biocare's most recent Global Symposium

Danaher's dental platform reportedly reaches 99 percent of all dental practices through an extensive network of dealer partners as well as direct sales. It will continue its strategy of working closely with distribution partners as well as direct sales.

"Nobel Biocare's leadership team has done an outstanding job creating a strong platform for future growth over the last couple of years," van Duijnhoven added. "Our team is excited to work with CEO Richard Laube and the Nobel Biocare team to build on their efforts toward continued innovation, growth and business improvement. We look forward to welcoming all Nobel Biocare's associates, customers and key opinion leaders to the Danaher team."